 Home > Biochemical Engineering > Polypeptide > Tirzepatide Peptide Powder Lyophilized Vial For Lab Research

Tirzepatide Peptide Powder Lyophilized Vial For Lab Research buy - large image1

Tirzepatide Peptide Powder Lyophilized Vial For Lab Research

Name: Tirzepatide Peptide Powder Lyophilized Vial For Lab Research
SKU: pr2609162358
Price: 85 USD
Availability: InStock

Unit Price:

$85-100/UNIT FOB

Get Latest Price 

Grade:

Research Grade

Content:

99%

Port:

qingdao

Packaging:

10 vials / kit

Price valid (until):

2026-10-16

Contact Supplier

 Chat Now

Jiangsu Lilly Bio

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Cosmetics

 Visit Store

Product Description
Seller Information

Description
Product Detail
Product Name：Tirzepatide

CAS：2023788-19-2

Molecular Formula：C₂₂₅H₃₄₈N₄₈O₆₈

Molecular Weight：4813.527

Appearance：White lyophilized powder

Purity：≥99% (HPLC)

Sequence：H-Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(Eicosanedioyl-isoGlu-PEG2-PEG2)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂

Product Description

Tirzepatide is a synthetic 39-amino-acid dual GIP/GLP‑1 receptor agonist peptide. It can activate both GIP and GLP‑1 receptors, widely used for scientific research on glucose metabolism and weight related studies. Our tirzepatide powder is manufactured under strict peptide synthesis process, each batch comes with COA, HPLC and MS test reports.
Basic Info

Product Name:
Tirzepatide, Tirzepatide powder, Tirzepatide lyophilized powder, Tirzepatide peptide, high purity Tirzepatide

Categories:
Polypeptide

Research

Class:
Dual agonist — GIPR, GLP-1R

Status:
FDA-approved (Mounjaro / Zepbound)

Mechanism:
Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

EC50 (Human GLP1R):
0.934 nM

EC50 (Human GIPR):
0.0224 nM

Source:
Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

Clinical Development:
NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503

FDA:
Mounjaro, Zepbound (approved 2022-05-13)

References

ChEMBL:
CHEMBL4297839

DrugBank:
DB15171

KEGG DRUG:
D11360

PubChem:
PubChem

Literature:
NEJM: Frias et al. (2021) — SURPASS-2; FDA: Mounjaro (NDA 215866)

Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Seller Information

Business Type:
Trader

Main Products:
Cosmetics

Location:
Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone

Year of Establishment:
2026
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

Tirzepatide Peptide Powder Lyophilized Vial For Lab Research

Product Description

Seller Information

Product Description

Related Products

Related Searches

More from this Seller